** Brokerage Stephens cuts price target for home health services provider Addus HomeCare ADUS.O to $142 from $153; maintains "overweight" rating

** The new PT represents 45.5% upside to stock's last close

** Brokerage says uncertainty over funding for federal health insurance program Medicaid has been pushing the stock lower as the co's patient population can be impacted

** Stock closed 10.4% lower on Tuesday, and has shed about 22% YTD

** ADUS, however, views its position of low-cost settings serving older adults and disabled population within Medicaid as likely more insulated from the broader potential reductions

** Company, after market close on Monday, posted quarterly adj. profit of $1.38/shr compared with analysts' estimate $1.35/shr, according to data compiled by LSEG

** 11 of 12 brokerages rate the stock "buy" or equivalent, and one "underweight"; their median PT is $138 - data compiled by LSEG

** ADUS rose 33.3% in 2024

(Reporting by Siddhi Mahatole)

((Siddhiprabhanjan.mahatole@thomsonreuters.com))